B&L Expanded Drug-Delivery Products Seen As Springboard To Future Growth

Bausch & Lomb continues to transform itself into a drug-delivery eyecare company from a traditional contact lens firm, with implants and molecular compounds in various stages of development

More from Archive

More from Medtech Insight